Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

TOP NEWS: Haleon to start trading in London on July 18 - FTSE Russell

15th Jun 2022 19:31

(Alliance News) - FTSE Russell on Wednesday said it expects Haleon, the Consumer Healthcare arm of GSK PLC, to commence trading on the London Stock Exchange on July 18. Read More

TOP NEWS: Sanofi, GSK booster jab impresses against Omicron

13th Jun 2022 08:52

(Alliance News) - Sanofi SA on Monday said its Covid-19 booster jab developed alongside GSK PLC delivers a stronger immune response to the Omicron variant than other jabs. Read More

LONDON BRIEFING: Pound hit as weak UK economy puts rate hikes in doubt

13th Jun 2022 08:18

(Alliance News) - The UK economy unexpectedly contracted again in April, leaving the Bank of England in a tough spot when it meets later this week. Read More

LONDON MARKET MIDDAY: Stocks down as investors await US inflation data

10th Jun 2022 12:17

(Alliance News) - Stock prices in London were lower at midday on Friday with market focus squarely on the upcoming US consumer price index report at 1330 BST. Read More

LONDON MARKET OPEN: GSK rises as RSV vaccine succeeds in trial

10th Jun 2022 08:57

(Alliance News) - Stock prices in London opened lower on Friday with trepidation ahead of US inflation data in the afternoon, while GSK bucked the market trend on upbeat late-stage trial results for a vaccine. Read More

TOP NEWS: GSK closer to first respiratory syncytial virus vaccine

10th Jun 2022 08:14

(Alliance News) - Drugmaker GSK PLC on Friday said its vaccine candidate for respiratory syncytial virus, or RSV, showed positive phase three data in older adults. Read More

LONDON MARKET PRE-OPEN: GSK get positive RSV vaccine trial results

10th Jun 2022 07:55

(Alliance News) - Equities in London are seen opening lower on Friday with investors cautious ahead of key US inflation data at 1330 BST. Read More

GSK wins FDA approval for measles, mumps and rubella vaccine Priorix

6th Jun 2022 10:05

(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has approved its Priorix vaccine for active immunisation for the prevention of measles, mumps and rubella in individuals of 12 months of age and older. Read More

LONDON MARKET PRE-OPEN: Melrose sells Ergotron for USD650 million

6th Jun 2022 07:46

(Alliance News) - Stock prices in London are seen opening higher on Monday, following the long holiday weekend in the UK, tracking gains in Asian equity markets as Beijing further relaxed pandemic restrictions. Read More

LONDON MARKET CLOSE: No jubilee euphoria as inflation fears remain

1st Jun 2022 17:06

(Alliance News) - Stocks in London ended lower on Wednesday ahead of the extra long Jubilee bank holiday weekend as investors weigh inflation and interest rates. Read More

UPDATE: Pfizer to exit 32% stake in GSK consumer JV Haleon after float

1st Jun 2022 11:58

(Alliance News) - GSK PLC on Wednesday said it has submitted to the UK Financial Conduct Authority its plan for the demerger of its consumer healthcare arm and its listing in London and New York as Haleon. Read More

TOP NEWS: GSK files plan for consumer arm demerger with UK regulator

1st Jun 2022 09:05

(Alliance News) - GSK PLC on Wednesday said it has submitted to the UK Financial Conduct Authority its plan for the demerger of its consumer healthcare arm and its listing in London and New York as Haleon. Read More

LONDON BRIEFING: Tullow Oil and Capricorn Energy set all-share merger

1st Jun 2022 08:26

(Alliance News) - Tullow Oil and Capricorn Energy on Wednesday said they have agreed to an all-share merger. Read More

LONDON MARKET CLOSE: Big oil lifts FTSE 100 as inflation hits Europe

31st May 2022 17:07

(Alliance News) - Stocks in London ended mixed on Tuesday with oil majors helping lift the FTSE 100, while the European counterparts grappled with record inflation. Read More

IN BRIEF: GSK JV ViiV gets marketing approval for Vocabria in Japan

31st May 2022 10:45

GSK PLC - London-based pharmaceutical firm formerly known as GlaxoSmithKline - Notes ViiV Healthcare Ltd received marketing approval by Japan's Ministry of Health, Labour, & and Welfare for Vocabria used in combination with Rekambys and Edurant. Read More

TOP NEWS: GSK gives vaccine business shot in the arm with US purchase

31st May 2022 09:22

(Alliance News) - GSK PLC on Tuesday said it has agreed to buy Affinivax Inc for up to USD3.3 billion, to gain access its "highly innovative" next-generation 24-valent pneumococcal vaccine candidate. Read More

LONDON MARKET OPEN: Slow start with Russia oil ban, inflation in mind

31st May 2022 08:57

(Alliance News) - The FTSE 100 was outperforming European peers on Tuesday morning, as blue-chip benchmarks on the continent were suffering after EU leaders agreed a partial ban on Russian oil. Read More

LONDON BRIEFING: GSK expands in vaccines ahead of consumer split

31st May 2022 08:27

(Alliance News) - GSK on Tuesday said it has agreed to pay USD2.1 billion upfront, with potentially a further USD1.2 billion coming, to acquire Boston, Massachusetts-based Affinivax. Read More

LONDON MARKET PRE-OPEN: B&M taps CFO for CEO; GSK expands in vaccines

31st May 2022 07:54

(Alliance News) - Stocks in London were called flat on Tuesday with a mixed session in Asia unable to inspire, as investors await an inflation reading due from the eurozone. Read More

IN BRIEF: GSK taps further talent for Haleon board

30th May 2022 13:12

GSK PLC - west London-based pharmaceutical firm formerly known as GlaxoSmithKline - Makes further appointments to the designate board of Haleon, the independent company to be formed following the demerger of its Consumer Healthcare business. GSK's nominations for independent non-executive directors are Asmita Dubey, chief digital & marketing officer at L'Oreal SA who built the company's first joint businesses with Alibaba Group Holding Ltd and Tencent Holdings Ltd, and Marie-Anne Aymerich who led the worldwide Oral Care category at Unilever PLC. Read More

FTSE 100 Latest
Value8,287.42
Change11.76